DIALYSIS-TIR Study
Public ClinicalTrials.gov record NCT06042153. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Semaglutide for Dialysis-Treated Patients - a Glucose Time in Range Study- DIALYSIS-TIR Study
Study identification
- NCT ID
- NCT06042153
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 43 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 4, 2023
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2028
- Last update posted
- Jan 12, 2026
2023 – 2028
United States locations
- U.S. sites
- 5
- U.S. states
- 2
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Davita UT Southwestern - Oak Cliff | Dallas | Texas | 75224 | — |
| DaVita UT Southwestern - East Dallas | Dallas | Texas | 75228 | — |
| DaVita UT Southwestern - Preston | Dallas | Texas | 75240 | — |
| DaVita UT Southwestern - Irving | Irving | Texas | 75062 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Type 2 Diabetes trials
Other public records listing Type 2 Diabetes. Sorted by last update posted; newest first. Not a recommendation.
- NCT07797335: AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications Recruiting
- NCT07778524: Alpelisib Challenge Test (ACT) Not yet recruiting
- NCT07754461: A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar Not yet recruiting
- NCT07743307: Feasibility of a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 Diabetes Not yet recruiting
- NCT07032844: Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT) Recruiting
- NCT07731399: Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06042153, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06042153 live on ClinicalTrials.gov.